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Key messages  
A resurgence in syphilis among gay, bisexual and other men who have sex with men (MSM) has been detected in England. 
Increases in high risk sexual behaviour, such as chemsex among MSM living with HIV in England is thought to be linked to the increased 
use of use of anti-retroviral therapy (ART) and is major factor in the increasing diagnoses of STIs. 
There was no significant evidence of an increased risk of syphilis in MSM receiving ART. 
Abstract 
Objective: A resurgence in bacterial sexually transmitted infections (STIs), notably syphilis, among gay, bisexual and other men who have 
sex with men (MSM) has been detected in England. A Canadian modelling study postulated that anti-retroviral treatment (ART) may 
increase susceptibility to syphilis. We assess the association between ART and syphilis incidence in a comprehensive national cohort of 
MSM living with HIV in England.  
Methods:  National surveillance data were used to create a cohort of MSM attending for both HIV and STI care in England between 2009-
2016. Survival analysis was used to calculate the incidence of infectious syphilis during periods on and off ART. Multivariable Poisson 
regression was used to assess the association between ART use and syphilis, after adjustment for potential confounders, including, as a 
proxy measure for high-risk behaviour, being diagnosed with >1 other STI prior to a syphilis diagnoses.  
Results: 19,428 HIV diagnosed MSM contributed 112,960 person-years of follow-up from 2009-2016. The overall rate of syphilis was 78.0 




(absolute rate difference 4.7 cases per 1,000 person-years). Multivariable analysis showed no statistical association between receiving ART 
and syphilis. Increased risk of syphilis was found in MSM aged 25-34 (HR:1.89, 95% CI:1.43-2.51) and in those diagnosed with two other 
STIs (HR:5.83, 95% CI:5.37-6.32).  
Conclusion: Whilst we observed a small increase in the rate of syphilis among those on ART, when adjusting for potential confounding 
factors, including a proxy measure for high-risk behaviour, there was no evidence of an increased risk of syphilis in MSM receiving ART. 
High-risk sexual behaviour markers were the main risk factors for syphilis and our results highlight the need for STI prevention 
interventions in MSM living with HIV to target these particularly high risk sexual networks. 
Introduction  
A resurgence in bacterial sexually transmitted infections (STIs) has been observed in England in recent years, especially among gay, 
bisexual and other men who have sex with men (MSM) [1]. Between 2012 to 2019 the number of syphilis diagnoses among MSM in 
England increased from 2,138 to 5,687 (increase of 166%)[2]. Increases in other bacterial STIs were also seen among this group, with 
chlamydia diagnoses increasing from 8,341 to 23,187 (increase of 178%) and diagnoses of gonorrhoea from 10,933 to 33,853 (increase of 
210%).  
Among MSM, HIV/STI co-infections, particularly syphilis, represent a significant public health problem [3].  A major factor in the increasing 
diagnoses of STIs among MSM living with HIV in England is thought to be changes in sexual behaviour and increased high-risk sexual 
behaviour which have been linked to the increased use of anti-retroviral therapy (ART). It has been suggested that there has been an 
increase in some high-risk behaviours such as chemsex (the use of drugs before or during planned sexual activity to sustain, enhance, 
disinhibit or facilitate the experience) [4-6] and a reduction in behaviours such as serosorting (selecting partners based on their HIV 
status), which is likely associated with both a reduction in the stigma towards HIV which is now often considered a chronic, manageable 
condition and the increased widespread use of ART.  
Non-behavioural changes have also been suggested to explain the marked increase in syphilis over the last decade. More frequent 
monitoring of individuals with HIV may partially explain the elevated rates of STIs, particularly those who are asymptomatic [4]. Since 
2014, UK national guidelines have recommended that all sexually active MSM test for STIs at least annually and those at high risk of STI 
acquisition, indicated by condomless sex with new partners and drug use, test after every episode of condomless sex [7]. A result of this, 
an increased emphasis on screening was observed through the number of sexual health screens among MSM which increased by 65% 
(149,909 to 248,154) between 2014 and 2018 [2, 6].
 
This increase may help to explain the increasing rates of STI diagnoses among this 
group. An alternative hypothesis for the recent increase in STIs is the emergence of Treponema pallidum (T. pallidum) strains with 
increased transmissibility [3], however adequate genomic data does not currently exist to support this hypothesis.  
A recent Canadian modelling study by Rekart et al of HIV-1 and T. pallidum coinfection from 2005 and 2014 showed that both behavioural 
change and the use of ART substantially increased syphilis prevalence at baseline [8]. The authors concluded the behavioural impact of the 
use of ART could not fully explain the ongoing outbreak and that the immunological effects of ART may directly alter the host immune 




To establish whether, using surveillance data, we also find a relationship between factors other than behavioural among those using ART 
and the incidence of syphilis in England as found by Rekart et al in Canada, in this study, we look for evidence to support this hypothesis by 
assessing the association between ART and syphilis incidence, in a national cohort of MSM living with HIV in England. Identifying any 
association between the incidence of syphilis and ART use that could be contributed to factors other than behavioural factors could 
provide us a better understanding of the syphilis epidemic among MSM living with HIV and indicate the need for further research into the 




We performed a retrospective cohort analysis of all MSM receiving both HIV and STI care in England between 2009 and 2016 using HIV 
and STI surveillance data. To investigate the association between ART status and the incidence of syphilis we calculated the rates of 
syphilis (primary, secondary and early latent) in MSM living with HIV during periods on and off ART. Sensitivity analysis was carried out by 
including cases of primary syphilis only and as a comparator, the same methods were used to assess the rates of chlamydia and 
gonorrhoea on and off ART.  
Data sources 
Data on persons living with HIV were obtained from the HIV and AIDS Reporting System (HARS), a pseudonymised national cohort of all 
persons diagnosed with HIV and accessing specialist HIV care in the UK. Data, including ART status, are regularly updated at least annually 
by all service providers [9]. Data on STIs were obtained from the GUMCAD STI surveillance system, the national STI surveillance system in 
England [10]. GUMCAD records all attendances at all publicly commissioned sexual health clinics and collects information including STI 
testing and diagnosis details, patient registration information such as, demographic information including, ethnicity, country of birth, age, 
sexual orientation [9, 11]. Patient records are pseudonymised and can be linked within but not across clinics using clinic numbers that are 
unique to each individual.  
 
Using a combination of clinical (clinic identification code, clinic site code, local authority of clinic and date of diagnoses) and demographic 
characteristics (gender, year of birth, ethnicity) we identified MSM living with HIV in HARS who also attended for STI care in GUMCAD.  
Matching between the GUMCAD dataset to the HARS dataset was carried out for two groups of patients captured within the GUMCAD 
dataset; a) individuals who were reported as living with HIV in the GUMCAD dataset and b) individuals who were not reported as living 
with HIV in GUMCAD were matched. Data matching was carried out using a verified matching algorithm that was previously used to match 
tuberculosis and HIV data [12]. Only individuals who matched between both datasets were included in the study. A dataset was created 





The study population comprised MSM aged >15, living with diagnosed HIV and who had an episode of clinical care captured in both HARS 
and GUMCAD during the study period which ran from 2009 to 2016. Using the HIV diagnosis date reported in HARS we determined the 
initiation of follow up for each individual within the matched dataset. For men diagnosed with HIV before 1
st
 January 2009, when the 
GUMCAD surveillance system was initiated, we considered the start of their follow-up time to be the 1
st
 January 2009. For men diagnosed 
with HIV after the 1
st
 January 2009 we took the start of their follow-up time to be the first recorded visit date in GUMCAD after their HIV 
diagnosis date. Individuals contributed person-years at risk from their entry into the cohort to their last attendance date reported in 
GUMCAD before December 2016, when follow up was censored. 
Data analysis  
Based on information reported to HARS, individuals were classified as either on or off ART treatment at each GUMCAD attendance. This 
was used to indicate ART status during each period between attendances reported in GUMCAD and was based on the most recently 
recorded ART status in HARS within one year prior to each GUMCAD attendance. CD4 count was categorised into <200, 200-349, 350-499 
and >500 cells per mm
3
 and viral load was categorised into <50 (virally suppressed), 50-200 and >200 copies/ml. There was no evidence 
for co-linearity between CD4 count and viral load within the data.  We included episodes of early syphilis (primary, secondary or early 
latent syphilis) but not late syphilis (late latent or tertiary), as reported in GUMCAD. For the purpose of these analyses, we considered 
episodes of chlamydia or gonorrhoea each as single infections irrespective of the anatomical site of infection.  
For use as a proxy measure of high risk sexual behaviour, we calculated the number of other bacterial STIs (chlamydia, gonorrhoea or 
syphilis) each individual was diagnosed with during their time in the study period, an approach that has previously been validated as a 
proxy marker using GUMCAD data [13]. For example, when analysing rates of syphilis, we calculated the total number of chlamydia and/or 
gonorrhoea diagnoses (other bacterial STIs) that an individual had reported in GUMCAD prior to their syphilis diagnosis. We categorised 
these counts as none, one or two or more episodes of other bacterial STIs.  
To investigate the impact of the use of ART on syphilis we calculated the crude incidence of syphilis per 1000 person-years.  A 
multivariable random-effects Poisson model was fitted to assess associations with the risk of each STI after adjustment for the following 
confounders: age, ART status, viral load, CD4 count, previous other bacterial STI diagnoses and year of diagnoses to account for secular 
trends.  
Ethical considerations 
The study was approved by the London School of Hygiene & Tropical Medicine research ethics committee (Reference:13542). The 
Caldicott Panel at Public Health England provided oversight and approval for matching the HARS and GUMCAD data for this analysis. In its 
role providing infectious disease surveillance, Public Health England has approval to handle data obtained by GUMCAD and HARS under 
Regulation 3 of the Health Service (Control of Patient Information) Regulations 2002. 






Of the 10,030,027 unique individuals who were reported to GUMCAD between 2009 and 2016, 151,679 were living with HIV or reported 
as newly diagnosed with HIV at some stage during this period and 73.4% (111,253) were matched to HARS. An additional 7,176 matched 
individuals who were not reported as living with HIV GUMCAD but had a confirmed HIV diagnosis in HARS were also included. The 
resulting matched dataset provided a cohort of 118,429 individuals, of whom 19,428 were MSM living with HIV who had a recorded care 
visit for their HIV in either HARS or GUMCAD between 2009 to 2016. These men contributed 115,621 person-years of follow-up. The 
median years of follow up was 6.5 years per person (IQR:3.7-8.4). 
 
Characteristics of the matched cohort of MSM living with HIV used in the analysis were compared to all MSM reported as living with HIV 
who are captured in the GUMCAD dataset to determine how representative the matched cohort was to the overall GUM attending 
population living with HIV.   
At baseline (measured at the matched individual’s first attendance in GUMCAD from 2009), there was evidence of statistically significant 
differences between the matched cohort and all men living with HIV who are captured in GUMCAD, whose baseline was measured at their 
first reported attendance in the GUMCAD dataset between 2009-2016. Statistically significant differences were seen in terms of age (p-
value=<0.0001) and in terms of ethnicity (p-value=<0.001). This difference in sample demographics is likely to be due to 45% of MSM 
within the matched cohort being diagnosed with HIV prior to the start of the follow period in 2009 and missing information on an 
individual’s HIV status in the GUMCAD dataset if previously diagnosed elsewhere. 
 
Among the 19,428 men in the cohort, 16,441 (85.2%) were white.  At the time of cohort entry, the median age was 41 (IQR:33-48), 87.4% 
were on ART with a median CD4 count of 530 cells/mm
3 
(IQR:393-700) and a median viral load of 49 copies/ml (IQR:39-216).  5,979 (33%) 
of men had an undetectable viral load at their first GUM attendance. Overall 82% of individuals who were not receiving ART at their first 
recorded visit initiated ART during the follow-up period. The median number of STI clinic attendances per year (as reported to GUMCAD) 
was 5 (IQR:3-9).  
There were a total of 429,829 STI clinic visits during the study period, and viral load data, obtained via the matching process, were 
available for 87.4% of these visits (375,745/428,829), CD4 count data were available for 80.8% of visits (347,000/429,829). Where 
information was available, the HIV viral load was reported as virally suppressed (<50 cells/ml) in 69.3% (260,289/375,745) of visits and the 
CD4 count was >500 cells/mm
3
 in 55.8% of clinic visits.  
Syphilis 
Over the entire study period the rate of syphilis was 32.5 cases per 1000 person years (1000/yrs) (Table1). The rate of syphilis increased 
from 28.78 per 1000/yrs in 2009 to 52.06 per 1000/yrs in 2016 (Table 2). In univariable analysis, the rate of syphilis was highest among 
men aged 25-34 (41.13 per 1000/yrs 95% CI:38.63-43.78 P<0.05) and 35-49 (36.84 per 1000/yrs 95% CI:35.32-38.42 P<0.05) compared 
with those aged over 65, the age group showing the lowest risk of syphilis. The rate of syphilis was higher among men receiving ART (36.85 
cases per 1000/yrs 95% CI:35.56-38.20 P<0.05), compared to those not receiving ART (32.64 cases per 1000/yrs 95% CI:30.25-35.21 
P<0.05). Whilst this increased rate compared to men not receiving ART was significant, the absolute rate difference was only 4.21 cases 
per 1000/yrs. Syphilis was most common among men with a high CD4 count (>500 cells per mm
3




<500 cells per mm
3
 and among those with a viral load of <50 cells/ml compared to those with a viral load >50 cells/ml. The rate of syphilis 
was strongly associated with a diagnosis of other bacterial STIs during the study period. Individuals diagnosed with two or more other 
bacterial STIs saw a rate of syphilis of 91.31 cases per 1000/yrs (95% CI:87.46-95.33 P<0.05), compared to those were only diagnosed with 
one STIs, with a rate of 14.53 (95% CI:13.70-15.41 P<0.05) cases per 1000/person-years.  
In multivariable analysis both age and being diagnosed with other bacterial STIs remained strongly associated with the risk of syphilis. 
Compared to men who were not diagnosed with another STI, the risk of syphilis was significantly higher among both men with a single 
other bacterial STI (HR:2.93, 95% CI:2. 653.24 P<0.05) and those diagnosed with two or more other bacterial STIs (HR:5.83, 95% CI:5.37-
6.32 P<0.05). The risk of syphilis was highest among individuals aged 25-34 (HR:1.89, 95% CI:1.43-2.51  P<0.05) and 35-49  (HR:1.88, 95% 
CI:1.43-2.48 P<0.05). After adjustment for confounders, ART use was not significantly associated  with an increased  risk of syphilis 
(HR:1.12, 95% CI:0.99-1.27) (Table 2). 
 




Rate* (per 1000 
person-years) 
Upper CI (95%) Lower CI  
(95%) 
Syphilis 3671 112.96 32.50 31.46 33.57 
Chlamydia 7606 112.96 67.33 65.83 68.86 
Gonorrhoea 8814 112.96 78.02 76.41 79.67 
Table 1. Rates of Syphilis, Chlamydia and Gonorrhoea among MSM between 2009 and 2016   










Lower 95% CI Upper 95%CI P value  
Age band 16-24 27.843 21.793 35.572 2.078 1.493767 1.027233 2.172185 0.036 
25-34 41.125 38.632 43.777 3.069 1.892169 1.428019 2.507182 0.000 
35-49 36.837 35.317 38.422 2.749 1.880326 1.427079 2.477527 0.000 
50-64 24.394 22.585 26.348 1.82 1.510372 1.138879 2.003042 0.004 
>65 (base) 13.4 10.313 17.413  1    
ART status On ART 36.853 35.557 38.196 1.129 1.1203 0.9905048 1.267104 0.071 
Not on ART (base) 32.639 30.252 35.214      
Missing 17.958 15.86 20.333 0.487 0.7069033 0.5813087 0.8596331 0.001 
CD4 category (cells per mm3) <200 19.376 15.25 24.618 0.472 0.809554 0.6281218 1.043393 0.103 
200-349 27.691 24.805 30.913 0.673 0.9546112 0.8420469 1.082223 0.468 
350-499 31.797 29.605 34.151 0.772 0.9004347 0.8246577 0.9831748 0.019 
>500 (base) 41.174 39.476 42.945  1    
Missing 24.971 23.066 27.033 0.606 0.8740689 0.7814686 0.9776419 0.018 
Viral Load category 
(copies/ml) 
<50 (base) 36.922 35.539 38.359  1    
50-200 33.658 28.973 39.101 0.912 1.019561 0.8682193 1.197283 0.813 
>200 33.121 30.759 35.664 0.897 0.9980841 0.8836522 1.127335 0.975 
Missing 22.504 20.413 24.809 0.609 0.9437805 0.7986513 1.115282 0.497 
Other bacterial STIs No other STIs (base) 14.528 13.699 15.407  1    
1 other STI diagnosis 44.666 41.541 48.026 3.074 2.933063 2.653683 3.241855 0.000 
2 or more other STI diagnoses 91.313 87.463 95.332 6.285 5.82641 5.372481 6.318692 0.000 
Year 
2009 28.782 24.049 34.447  1    
2010 24.266 21.336 27.598 0.843 0.8245479 0.6604729 1.029382 0.088 
2011 28.246 25.314 31.516 0.981 0.9335637 0.755377 1.153783 0.525 
2012 24.027 21.526 26.818 0.835 0.7744598 0.6262373 0.9577646 0.018 
2013 26.59 24.105 29.331 0.924 0.8442963 0.686264 1.03872 0.109 
2014 35.883 33.131 38.865 1.247 1.129241 0.9244973 1.379329 0.234 
2015 38.078 35.368 40.995 1.323 1.20973 0.9919012 1.475397 0.060 
2016 52.06 48.945 55.374 1.809 1.748079 1.437501 2.12576 0.000 
 
Table 2: Univariate and multivariate random-effects Poisson model analysis of Syphilis among MSM between 2009 and 2016    





Primary syphilis  
In a sensitivity analysis including only cases of primary syphilis the risk of syphilis was not associated with ART use (HR:1.13, 95% CI:0.92-
1.40). The risk of primary syphilis was strongly associated with being diagnosed with two or more other bacterial STIs (HR:5.14, 95% 
CI:4.49- 5.91). 
Chlamydia and gonorrhoea  
Over the entire study period the rate of chlamydia was 67.3 cases per 1000/yrs and gonorrhoea, 78.02 cases per 1000/yrs (Table1). 
Univariable analysis showed MSM not on ART had significantly higher rates of chlamydia (83.12 cases per 1000/yrs 95% CI:79.26-87.18) 
than those on ART (Rate ratio:0.83); gonorrhoea rates were also higher among those not on ART (100.92 cases per 1000/yrs 95% CI:96.99-
105/38). When adjusting for potential confounders, the rate of chlamydia was lower among MSM on ART (HR:0.95, 95% CI:0.87-1.03), but 
this difference was not significant; the rate of gonorrhoea was significantly lower among MSM on ART (HR:0.93, 95% CI:0.86-1.01).  
Limitations  
There are several limitations in our study. Missing data on ART and HIV status at some STI attendances, may have introduced selection 
bias. Furthermore, the data recorded in the HIV dataset only allowed us to classify ART status as receiving or not receiving ART in a given 
year. We were not therefore able to explore associations between ART use and syphilis by class of ART or regimen. A methodological 
limitation is that ART status was carried forwards within the most recent year, therefore there is a possibility that some patients’ ART 
status changed more frequently than was captured in our dataset. However, ART uptake is high among MSM in the UK (>95%) with high 
viral suppression (>95%) suggesting high adherence to ART[14], and behavioural surveys have found most  people receiving ART treatment 
only miss one or two tablets a week[15]. We included time as a variable to account for overall secular trends, which demonstrate an 
overall rise in the number of cases of syphilis over the study period in the UK. Auto-correlation of time dependent variables can bias effect 
estimates although we note that the unadjusted rates of syphilis in individuals receiving or not receiving ART are similar suggesting this is 
unlikely to have significantly impacted our findings.  
Additionally, although matching between the HIV and STI datasets was generally good, differences between the HIV and STI surveillance 
variables meant that there were limitations to the matching processes.  The representativeness of this sample is difficult to assess, 
therefore extrapolation of our findings to all MSM living with HIV should be done with caution. Finally, we could not measure high-risk 
sexual behaviour directly and instead generated a behavioural proxy based on other bacterial STI coinfections. This approach has 
previously been validated [16], however, people are likely to go in and out of high risk periods and it is likely we have overestimated 
periods of high-risk which would potentially underestimate their effect in our model[13].  
Additionally, any associations between ART and syphilis may be confounded by secular trends; we noted marked increases in the rates of 
syphilis, chlamydia and gonorrhoea in the period 2009-2016 suggesting broader secular trends in sexual networking and risk-taking may 
explain increases in syphilis during the study period. This temporal increase may confound the association between ART and syphilis, as 
the introduction of revised ART guidelines in the UK in 2011 [17] led to a greater proportion of people living with HIV starting ART in more 






Using nationally comprehensive data on MSM living with HIV, we found a higher incidence of syphilis among those on ART compared to 
those not on ART, an association that was not found with chlamydia or gonorrhoea.  However, after adjusting for confounders, the there 
was no evidence of a statistically significant association between syphilis and ART. The higher incidence of syphilis in MSM on ART is 
therefore likely driven by higher risk behaviours, as evidenced by the increased risk found in men meeting our proxy measure for high-risk 
(at least 2 other STIs).  
Although no significant association is seen, the results show higher rates of syphilis among virally supressed individuals (<50 copies/ml) 
and those with a high CD4 count (>500 cells per mm
3
). This may suggest some indirect association between the use of ART and syphilis 
incidence. However, our findings do not provide evidence to support the hypothesis postulated by Rekart and colleagues that an increased 
risk of syphilis seen among MSM is due to a direct action of ART, nor that increased ART rollout can directly explain the recent significant 
increase in the number of syphilis cases seen in England. 
The lack of association between syphilis and ART is also in keeping with studies of STI rates among people receiving pre-exposure 
prophylaxis for HIV (PrEP). Studies have reported varying impacts on the risk of bacterial STIs among individuals receiving PrEP. Whilst 
there is some evidence the rate of bacterial STIs is increased among individuals receiving PrEP, likely reflecting behavioural changes and 
increases in STI testing frequency, there is no evidence of a disproportionate change in the risk of syphilis[18-20]. 
Despite its limitations, this analysis was performed using one of the most comprehensive national HIV cohorts, including clinical data on 
persons accessing HIV care and STI diagnoses captured through a national prospective dataset using standardised criteria. To our 
knowledge, this is the largest study ever conducted to assess the association between ART use and the risk of syphilis. Despite finding no 
clear evidence of a link between ART and syphilis, our results do highlight considerable increases in the rates of syphilis in MSM living with 
HIV over the study period 2009 to 2016. Further investigation using more robust behavioural data is needed to investigate into the 
potential reasons for this increase are needed to provide improvements in the prioritisation of the screening, diagnosis and treatment of 
STIs in MSM. Improved strategies to target these particularly high risk sexual networks are needed to reduce the incidence of bacterial STIs 
among high risk men. 
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